ACCESS Newswire

Biovica International

16.11.2021 09:38:17 CET | ACCESS Newswire | Press release

Share
Biovica’s DiviTum(R)TKa Results Published in Journal of Medical Economics

UPPSALA, SWEDEN / ACCESSWIRE / November 16, 2021 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II)

Biovica, active in cancer diagnostics, today announced that the results of a DiviTum®TKa budget impact model have been published in the Journal of Medical Economics. This publication expands on data presented at the ISPOR 2021 meeting. The model's results show that monitoring with DiviTum®TKa may achieve savings of up to three times the extra spend relative to current management of metastatic breast cancer patients.

Care for metastatic breast cancer patients is a large burden on healthcare systems due to cost of therapies, cost of monitoring tests, and management of side effects. The results from this study show that adding DiviTumTKa to care could give a net reduction in costs of up to three times the spend on the new test. The savings come from a decrease in the usage of other monitoring tools such as CT scans and bone scans, and from shortening the amount of time a patient receives expensive medical treatments that ultimately prove to be ineffective.

"Our analysis showed that inclusion of DiviTum®TKa could reduce use of a substantial proportion of traditional monitoring. If use of DiviTum®TKa can also predict lack of benefit from costly CDK4/6i therapy and clinicians then act on that information in a timely fashion, our model suggests that this will result in substantial cost savings to patients and health plans," said Scott D. Ramsey from the Fred Hutchison Cancer Research Center.

"This analysis reinforces our belief that DiviTum®TKa will improve the lives of patients and reduce costs in healthcare. From discussions with patients, we also know that they prefer a regular blood test as a better option than current monitoring practices." said Anders Rylander, CEO of Biovica.

The study publication is included in the November 2021 issue of the Journal of Medical Economics https://doi.org/10.1080/13696998.2021.2003674

Contact

Anders Rylander, CEO
Phone: +46-18-444 48 35
E-mail: anders.rylander@biovica.com

Biovica - Treatment decisions with greater confidence

Biovica develops and commercializes blood-based biomarker assays to evaluate efficacy of cancer treatments. Biovica's assay DiviTum® measure cell proliferation by detecting a biomarker in the blood stream. The assay has successfully demonstrated its capabilities to early evaluate therapy effectiveness in several clinical trials. The first application for DiviTum is monitoring of treatment for patients with metastatic breast cancer. Biovica's vision is that all cancer patients will get an optimal treatment from day one. Biovica collaborates with world-leading cancer institutes and pharmaceutical companies. DiviTum is CE-marked and registered with the Swedish Medical Products Agency. Biovica's shares are traded on the Nasdaq First North Growth Market (BIOVIC B). FNCA Sweden AB is the company's Certified Adviser, info@fnca.se , +46 8 528 00 399. For more information please visit: www.biovica.com .

Attachments

Biovica's DiviTum®TKa results published in Journal of Medical Economics

SOURCE: Biovica International



View source version on accesswire.com:
https://www.accesswire.com/673068/Biovicas-DiviTumRTKa-Results-Published-in-Journal-of-Medical-Economics

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

Tenstorrent Unveils TT-QuietBox(TM) 2, the First RISC-V AI Workstation With a Fully Open-Source Stack to Deliver Teraflop-Class Inference11.3.2026 17:00:00 CET | Press release

Liquid-Cooled Desktop System Runs Models up to 120B Parameters Locally With a Fully Open-Source Stack, Starting at $9,999 SANTA CLARA, CA / ACCESS Newswire / March 11, 2026 / Tenstorrent, the AI computing company led by CEO Jim Keller, today announced TT-QuietBox™ 2 (Blackhole™). This whisper-quiet, liquid-cooled AI workstation runs models up to 120 billion parameters directly at your desk, ships with an entirely open-source software stack from compiler to kernel, and starts at $9,999. It marks the industry's first desktop AI workstation built on RISC-V architecture to deliver teraflop-class inference. The Inference Imperative The timing matters. Inference has quietly overtaken training as the dominant AI workload, now accounting for more than 55% of cloud AI infrastructure spending at $37.5 billion - and it is still accelerating. Yet, developers running these workloads face a stark choice: pay per-token cloud fees that compound as usage scales, or buy hardware locked to proprietary st

Clockwork.io Introduces A New Class of Fault Tolerance to End Failure-Driven GPU Waste in AI Training11.3.2026 14:00:00 CET | Press release

New TorchPass solution addresses a multi-million dollar challenge with AI infrastructure; uses Live GPU Migration to keep large-scale AI training running through hardware failures instead of forcing costly restarts PALO ALTO, CA / ACCESS Newswire / March 11, 2026 / Clockwork.io, the leader in Software-Driven AI Fabrics™- a programmable, vendor-neutral software layer that optimizes large-scale GPU clusters for real-time observability, fault tolerance, and deterministic performance-today announced the general availability of TorchPass Workload Fault Tolerance. This new class of software-driven fault-tolerance eliminates one of the most costly failure modes in large-scale AI training: catastrophic job restarts caused by infrastructure faults. Delivered as a core capability of the Clockwork.io FleetIQ™ platform, TorchPass applies the principles of Software-Driven AI Fabrics to distributed training, using Live GPU Migration to allow workloads to continue running through GPU failures, networ

Datavault AI CEO Nathaniel Bradley to Present at Luminary 2026 During Oscars Weekend in Los Angeles11.3.2026 12:00:00 CET | Press release

Datavault AI (Nasdaq:DVLT) Debuts Tokenized Legacy™ Platform and ADIO® Technology at Beverly Center Alongside Scott Page's My Moon Experience, Pink Floyd Live Performance, and Entertainment Industry Luminaries PHILADELPHIA, PA / ACCESS Newswire / March 11, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real‑world asset tokenization technologies, today announced that Chief Executive Officer Nathaniel (Nate) Bradley will deliver a featured presentation at Luminary 2026 - Film, AI, Music and Crypto Innovators, a premier conference taking place Saturday, March 14, 2026, at the Beverly Center (8500 Beverly Blvd, Suite 835, Los Angeles, CA 90048) as part of Oscars Weekend 2026. The Luminary 2026 event is produced by Space Blue/MMF (Dallas Santana) and Hollywood Road Show TV (Chantelle Borelli) and forms the centerpiece of a four-day entertainment and technology activation series running March 1

Context Management Powers Production-Ready AI Analytics at Enterprise Scale11.3.2026 09:00:00 CET | Press release

GoodData delivers governed semantics, grounded knowledge, guided behavior, and full observability for reliable AI analytics. SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / March 11, 2026 / GoodData today introduced Context Management, a governed contextual layer designed to enable production-ready enterprise AI analytics and agents. As organizations deploy AI assistants, copilots, and autonomous agents, they encounter a structural gap: AI lacks enforced business context, governance, and observability. AI pilots demonstrate potential, but moving AI into production exposes the deeper challenge of ensuring answers are consistent, safe, and explainable at scale. Without semantics and traceability, answers shift depending on phrasing. Business rules are applied inconsistently. When outputs change, teams can't explain why. For enterprises, this erodes trust and slows adoption. Many AI analytics platforms rely on prompts, inferred metadata, or loosely integrated document search. Context is sug

Telestream Expands Its Cloud Services with the Introduction of UP11.3.2026 08:05:00 CET | Press release

New cloud-native platform extends Telestream Cloud Services to support Global Ingest, automation, review, and real-time monitoring across hybrid and distributed production environments NEVADA CITY, CA / ACCESS Newswire / March 11, 2026 / Telestream, a global leader in media workflow technologies, today announced the expansion of Telestream Cloud Services with the introduction of UP, a new cloud-native solution designed to support Global Ingest, orchestration, review, and real-time monitoring in modern production environments. With UP, Telestream extends its cloud portfolio beyond high-scale cloud processing and hybrid workflow extension, addressing the growing operational demands of distributed, IP-based media production. As media organizations navigate cost pressures, audience fragmentation, and increasingly distributed production models, cloud adoption has accelerated rapidly but unevenly. Some companies are extending trusted workflows into elastic cloud environments. Others are buil

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye